Ratings Aflac Incorporated

Equities

AFL

US0010551028

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
83.61 ^USD	-0.14%		+0.46%	+1.35%

Apr. 15	Morgan Stanley Raises Price Target on Aflac to $84 From $80, Maintains Equalweight Rating	MT
Apr. 11	Wells Fargo Cuts Price Target on Aflac to $81 From $83, Keeps Equalweight Rating	MT

Strengths

Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
The company is highly valued given the cash flows generated by its activity.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
AFLAC INCORPORATED	+1.35%	48.11B	B
METLIFE, INC.	+6.49%	50.92B	B+
MANULIFE FINANCIAL CORPORATION	+9.53%	42.2B	B+
PRUDENTIAL FINANCIAL, INC.	+6.55%	39.71B	B+
GENERALI	+19.34%	37.78B	B
SUN LIFE FINANCIAL INC.	+2.84%	30.07B	B
GREAT-WEST LIFECO INC.	-7.77%	27.56B	B-
PRUDENTIAL PLC	-18.42%	24.71B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+6.89%	21.99B	A
DAI-ICHI LIFE HOLDINGS, INC.	+20.69%	21.68B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes